3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
24
Fallopian Tube Neoplasms
20
Breast Neoplasms
10
Carcinoma, Ovarian Epithelial
8
Sarcoma
6
Neoplasms
4
Neoplasm Metastasis
4
Triple Negative Breast Neoplasms
3
Sarcoma, Kaposi
2
Sarcoma, Ewing
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Multi-centric Castleman's Disease
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, B-Cell
2
Leiomyosarcoma
2
Hodgkin Disease
2
Burkitt Lymphoma
2
Acquired Immunodeficiency Syndrome
2
AIDS-related Kaposi sarcoma
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Vaccinia
1
Uterine Cervical Neoplasms
1
Sarcoma, Synovial
1
Rhabdomyosarcoma
1
Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma
1
Recurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma
1
Recurrence
1
Peritoneal Neoplasms
1
Pancreatic Neoplasms
1
Interventions
Cyclophosphamide
3
ruxolitinib
2
fludarabine phosphate
2
fludarabine
2
Methotrexate
2
thymoglobulin
1
siltuximab
1
duvelisib
1
cc-486
1
calaspargase pegol
1
blinatumomab
1
Whole-Body Irradiation
1
Valganciclovir
1
Transplantation
1
Thiotepa
1
Therapeutics
1
Thalidomide
1
Tacrolimus
1
Radiotherapy
1
Prednisone
1
Positron-Emission Tomography
1
Polymerase Chain Reaction
1
Peripheral Blood Stem Cell Transplantation
1
Mycophenolic Acid
1
Mesna
1
Melphalan
1
Interleukin-6
1
Ifosfamide
1
Granulocyte Colony-Stimulating Factor
1
Ganciclovir
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Large Granular Lymphocytic
×
liposomal doxorubicin
×
1 year
×
Clear all
No trials found.